ArticleBMC ophthalmology2025
Efficacy of small incision lenticule extraction (SMILE), femtosecond-assisted laser in situ keratomileusis (FS-LASIK), and toric implantable collamer lens (TICL) implantation in correcting myopia with high astigmatism: a vector analysis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Preoperative and postoperative risk factors for persistent dry eye after corneal refractive surgery in ultra-high myopia: a retrospective cohort study.American journal of translational research · 2026Article
- Quantitative analysis of the effect of ocular rotation on postoperative residual astigmatism in small incision lenticule extraction for myopia correction.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeWe evaluated the efficacy of small incision lenticule extraction (SMILE), femtosecond-assisted laser in situ keratomileusis (FS-LASIK), and toric implantable collamer lens (TICL) implantation for correcting myopia with high astigmatism by vector analysis.
methodsThis retrospective study included 155 patients (155 eyes) with myopia and high astigmatism who underwent SMILE, FS-LASIK, or TICL implantation at our hospital. Patients were selected and divided into three groups based on the surgical procedure. The safety and effectiveness of three methods in correcting high astigmatism were compared, and the efficacy on high astigmatism were compared using Alpins' vector analysis.
resultsSix months after surgery, operative safety and effectiveness did not differ significantly among the implantation types. Postoperative cylinder and SE were higher in the SMILE and FS-LASIK groups compared to the TICL group (P < 0.05). Among the three groups, significant differences were observed in surgically-induced astigmatism (1.91 ± 0.46D vs. 2.14 ± 0.56D vs. 1.89 ± 0.63D), difference vector (0.43 ± 0.28 vs. 0.34 ± 0.24 vs. 0.80 ± 0.52), correction index (0.96 ± 0.15 vs. 1.02 ± 0.15 vs. 0.87 ± 0.21), angle of error (-3.38 ± 5.87°vs. -0.54 ± 4.04° vs. -7.23 ± 10.09°), flattening effect (1.87 ± 0.47 vs. 2.13 ± 0.57 vs. 1.74 ± 0.64), flattening index (0.93 ± 0.14 vs. 1.01 ± 0.15 vs. 0.80 ± 0.22), and index of success (0.23 ± 0.16 vs. 0.16 ± 0.12 vs. 0.38 ± 0.24) (P < 0.05).
conclusionsSMILE, FS-LASIK, and TICL implantation are all safe and effective for correcting myopia with high astigmatism. FS-LASIK demonstrated the best correction effect on high astigmatism, followed by SMILE and TICL implantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.